Class I

Drug Recall: PeakMax Capsules, 500 mg, packaged in 10 count blisters in cartons, Distributed by: PeakMax, San Francisco, CA, www.PeakMax.com

Boulla LLC · November 4, 2024

Reason for Recall

Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and diclofenac.

Distribution

Nationwide within the United States

States Affected

NATIONWIDE

Quantity Affected

Unknown

Source: FDA (openFDA Drug Enforcement)

Recall number: D-0084-2025

Status: ongoing

SafeCheck provides drug interaction information from FDA-approved product labeling (openFDA). This is for informational purposes only and is not medical advice. Always consult your healthcare provider before making medication decisions.

Boulla LLC Drug Recall: PeakMax Capsules, 500 mg, packaged in 10 count blisters in cartons, Distributed by: PeakMax, San Francisco, CA, www.PeakMax.com | SafeCheck